欧洲心血管疾病负担的性别差异:GBD 2023分析
基于2023年全球疾病负担研究,分析55个ESC成员国心血管疾病负担与风险因素的性别差异。2023年女性占病例55%和死亡50%,但疾病构成、风险暴露和地域差异显著不同;女性缺血性心脏病占比更低而外周动脉疾病更高,妊娠高血压疾病占女性心血管疾病发病25%。
要点
- 女性心血管疾病病例占55%、死亡占50%,但疾病构成与男性显著不同
- 女性缺血性心脏病占比21%低于男性38%,外周动脉疾病占比23%高于男性19%
- 妊娠高血压疾病占女性心血管疾病发病25%,国家间发病率差异达18倍
核心结论
- 欧洲心血管疾病总体负担男女相近,但疾病构成、风险暴露和地域差异存在显著性别差异。
- 女性非缺血性疾病和妊娠高血压疾病贡献大,需采取全生命周期和性别敏感的心血管预防策略。
研究设计与样本
- 基于2023年全球疾病负担研究的分析,覆盖55个ESC成员国,采用年龄-性别标准化率(每10万人年,2013年欧洲标准人口)评估1990-2023年趋势。
- 量化10种已确立心血管风险因素的年龄-性别标准化暴露汇总值,分析主要心血管疾病类别(含妊娠高血压疾病)的发病与死亡。
主要发现
- 女性缺血性心脏病占比21%低于男性38%;女性外周动脉疾病占比23%高于男性19%。
- 男性烟草和酒精暴露汇总值比女性高10-20个百分点;女性高体重指数和低体力活动暴露汇总值比男性高5-15个百分点。
- 女性最低与最高发病率国家间差异约3倍,男性约2倍;死亡率及早死差异更大,女性高达25倍。
- 妊娠高血压疾病占女性心血管疾病发病25%,国家间发病率差异高达18倍。
临床怎么用
- 心血管风险评估与预防应纳入性别特异因素,如妊娠高血压疾病史。
- 关注女性非缺血性心血管疾病和外周动脉疾病负担,避免将心血管疾病视为同质性疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite growing recognition of sex disparities in cardiovascular disease (CVD), contemporary, harmonized analyses of sex-specific burden in the European region that could inform targeted prevention strategies, remain limited. Sex-specific patterns in CVD burden and risk factor exposure across 55 European Society of Cardiology (ESC) member countries were examined using data from the 2023 Global Burden of Disease study. Risk factor exposure was quantified using age-sex-standardized summary exposure values for 10 established cardiovascular risk factors. Disease incidence and mortality for major CVD categories, including maternal hypertensive disorders, were estimated by calculating age-sex-standardized rates per 100 000 person-years using the 2013 European Standard Population. Analyses were performed by sex at country, regional, and ESC-wide levels and over time (1990-2023). In 2023, in the ESC region, the overall CVD burden was broadly similar in men and women, with women accounting for 55% (6.0 million) of cases and 50% of deaths (1.5 million). This apparent parity, however, concealed marked sex differences in disease composition, risk exposure, and geographic disparities. Compared with men, women had a lower proportion of CVD due to ischaemic heart disease (21% vs 38%) and a higher contribution from peripheral arterial disease (23% vs 19%). Major differences were also apparent in risk profiles, particularly for behavioural risk factors-with summary exposure values of tobacco and alcohol being 10%-20% points higher in men than women; contrasting with cardiometabolic factors, such as high body mass index and low physical activity, that were often 5%-15% points higher in women than men, and more modest differences in environmental and biological risks, including air pollution, fasting glucose, or cholesterol. Cardiovascular disease burden further varied widely across countries and disparities affected women more strongly than men, with an approximately three-fold difference between the lowest- and highest-incidence countries in women, compared with a two-fold difference in men, and even larger disparities in mortality and premature mortality (up to 25-fold in women). Maternal hypertensive disorders substantially shaped both the scale and composition of CVD burden in women, accounting for 25% of incident CVD in women and exhibiting substantial geographic variation, with up to 18-fold differences in incidence across countries. These findings challenge conventional approaches that treat CVD as a homogeneous condition. In particular, the substantial contribution of non-ischaemic conditions and maternal hypertensive disorders to the burden in women, alongside distinct patterns of risk exposure and wider geographic disparities, underscore the importance of adopting a life-course and sex- and gender-informed approach to cardiovascular prevention and policy.
引用
- Conrad N, Torbica A, Wood AM, et al. Sex differences in cardiovascular disease burden, risk factors, and disease spectrum in Europe: a global burden of disease 2023 analysis within the ESC Atlas framework. Eur Heart J. 2026. PMID: 42912409. doi:10.1093/eurheartj/ehag782
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。